New Test Predicts Risk for Recurrence for Patients With DCIS

Posted on January 23, 2012 by | Comments Off

Source: Newswise

Multigene assay predicts risk for local recurrence for patients with DCIS. This advance combines knowledge of the genome and new molecular technologies. Test allows physicians to individualize treatment so that lower-risk patients avoid radiation.

Click here to read more.

This entry was posted in Genomics, P4 Medicine, Personalized, Personalized Health Care, Personalized Medicine, Predictive and tagged , , , , , , , . Bookmark the permalink.

Comments are closed.